Business Daily Media

Men's Weekly

.

Immuno Cure BioTech acquires Shanghai Teresa Healthcare

Integrating Electroporation Technology & DNA Vaccine Platforms

HONG KONG SAR - Media OutReach - 20 September 2022 - Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies, announced today the acquisition of 92.6% of Shanghai Teresa Healthcare, the pioneer of electroporation technology and device in China.

The transaction will be settled in cash and shares. Teresa's shareholders will swap for about 1.5% equity in Immuno Cure while the inventor of Teresa's EP technology, Professor XU Yuhong (徐宇虹), maintains her 7.4% direct equity in Teresa.

Teresa EP device delivers brief electrical pulses to promote efficient penetration of DNA vaccine through cell membrane for the enhancement of gene expression and ultimate immune responses. It is the only such device approved by National Medical Products Administration for the administration of DNA vaccine in China. Such EP technology has been an integral part of Immuno Cure's DNA vaccine delivery strategy from research to clinical stage.

Founded in 2004, Shanghai Teresa is an innovative medical device group focusing in electro immunotherapies and rehabilitation therapies. In 2005, Teresa's electroporation technology was developed to enhance the delivery of DNA medicine, based on the intellectual property generated by Shanghai Jiao Tong University under the National 863 Project. Such EP technology has been proven safe and efficacious after deployment of over 10,000 times in collaboration with more than thirty hospitals for the administration of DNA medicine in numerous human trial subjects.

Immuno Cure has two PD-1-Enhanced DNA vaccines currently in phase 1 clinical trial for prevention of COVID-19 and therapeutic cure of HIV/AIDS.

Dr JIN Xia, CEO of Immuno Cure said, "Immuno Cure has partnered with Teresa over the years in developing customised EP delivery strategy for our PD-1-Enhanced DNA vaccines, which has brought about encouraging results in clinical setting recently. I am pleased with this convergence with Teresa, which will no doubt bring our teams even closer together. Teresa will continue to operate independently while leveraging on Immuno Cure's R&D platform for the development of their next generation non-invasive EP technology for intradermal delivery strategy. Immuno Cure is committed to support the continual growth and success of Teresa."

Ms. CHEN Liye, CEO of Teresa said, "Founded on our long term collaboration, Teresa is excited to become a member of Immuno Cure Group. This move will not only provide us with a much closer R&D relationship, which is essential for our technology advancement but also offer us the financial capability to meet future needs. Teresa treasures our collaborations with other players in the field and look forward to continuing our collaborations with new and sustainable EP technology."

Professor CHEN Zhiwei, Director of AIDS Institute at the University of Hong Kong and the Principal Scientific Advisor of Immuno Cure said, "Our research and development work at the AIDS Institute and Immuno Cure has benefitted from Teresa's EP technology and their diligent collaborative effort over the past 12 years. I am pleased to see their relationship developing into an even closer tie. Look forward to the development of the next generation of EP technology for further optimisation of delivery strategy and patient experience."

Dr Percy CHENG, Chairman of Immuno Cure concludes, "This transaction offers Immuno Cure the opportunity to secure Teresa's EP technology for support of not only R&D but also the clinical administration of our PD-1-Enhanced DNA vaccines. We are pleased with Professor XU's decision to remain as our co-investor in Teresa and are optimistic in the future of EP technology in our DNA vaccine development."Hashtag: #ImmunoCureBiotech

The issuer is solely responsible for the content of this announcement.

Immuno Cure BioTech

Immuno Cure BioTech is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development of vaccines and immunotherapies for cancers, inflammatory and infectious diseases based on its patented PD-1-Enhanced DNA vaccine and Anti-Δ42PD1 Blocking Antibody technology platforms.

To learn more about Immuno Cure BioTech, please visit

Shanghai Teresa Healthcare

Founded in 2004, Shanghai Teresa is an innovative medical device group based in Shanghai Zhangjiang Hi-Tech Park, focusing in electro immunotherapies and rehabilitation therapies.

To learn more about Shanghai Teresa Healthcare, please visit




News from Asia

Deleted

This Press release has been killed

Ausom Launches L1 ABE Electric Scooter with Full German Road Approval

HONG KONG SAR - Media OutReach Newswire - 15 October 2025 - Ausom’s new L1 ABE electric scooter is now available with full road approval in Germany—and for a limited time, it’s launching with spec...

Top Hong Kong Hotels 2025 | Regent Hong Kong Achieves Prestigious Recognition in Condé Nast Traveler Awards

HONG KONG / SINGAPORE - Media OutReach Newswire - 15 October 2025 - Regent Hong Kong proudly announces its recognition in the Condé Nast Traveler Readers' Choice Awards 2025 as one of the top 5 be...

Prudential NextGen Aces featured Exclusive On-Court Session and Panel Series with tennis icons Andre Agassi and Aryna Sabalenka

HONG KONG SAR - Media OutReach Newswire - 15 October 2025 - Prudential plc ('Prudential'), a leading life and health insurer and asset manager, today hosted the Prudential NextGen Aces, an event t...

OPPO ColorOS 16 Set for Global Unveil: A New Era of Smoothness, Intelligence, and Seamless Connectivity

SHENZHEN, CHINA - Media OutReach Newswire - 15 October 2025 - OPPO has revealed its first look at ColorOS 16, the latest version of its mobile operating system, launching with the upcoming Find X9...

Xsolla Brings Exclusive Event To Thailand With Xsolla Connect Bangkok: A Global Games Industry Gathering

Exclusive Event Brings Developers, Publishers, Investors, And Industry Leaders Together to Help Shape The Future Of Gaming BANGKOK, THAILAND - Media OutReach Newswire - 15 October 2025 - Xsolla, a...

APAC Employee Medical Plan Costs to Stabilise in 2026 After Two Years of Sharp Increase, Aon reports

China, India, Singapore, the Philippines and Vietnam projecting lower increases than previous year Cardiovascular diseases, gastrointestinal conditions and cancer are top medical ...

Singapore and Shanghai Professional Bodies Sign MOU to Empower Enterprises Through Cross-Border Collaboration

SINGAPORE - Media OutReach Newswire - 15 October 2025 – Professional and business communities from Singapore and Shanghai came together today in a landmark collaboration to deepen ties and empower...

Watch Exchange Turns Luxury Timepieces Into Hope: Charity Drive to Raise At Least S$100K for Elderly Care

"Give Time, Share Hope" campaign transforms dormant watches into tangible support for Geylang East Home for the Aged SINGAPORE - Media OutReach Newswire - 15 October 2025 – As Singapore's populati...

Coca-Cola: First in Hong Kong in Recycling Plastic Bottles to Create New Ones Leveraging Its Own Facilities

Continuing to advocate for and invest in well-designed collection systems to help reduce beverage packaging waste HONG KONG SAR - Media OutReach Newswire - 15 October 2025 - Coca-Cola in Hong Kong...

Qantas to Serve Nan’s Davidson Plum Cookie

Lake Macquarie, NSW (Awabakal Country): From a single mother’s kitchen bench to supermarket shelves, Wiradjuri entrepreneur Terri-Ann “Tezzi” Dani...

Minns Labor Government shutting down the Business Connect program

The NSW Opposition is concerned that the Labor government will shut down a support program that has assisted New South Wales businesses. In a media ...

Samsara Eco appoints Dr. Lars Kissau as General Manager for Asia

Australian biotech innovator Samsara Eco has announced the appointment of Dr Lars Kissau as its first General Manager of Asia. Based in Singapore...

From the first bounce to the final siren - small business lessons from the AFL Grand Final

The AFL Grand Final is one of the most anticipated days on the sporting calendar. This Saturday, the Geelong Cats and Brisbane Lions will battle i...

Australia’s top finance leaders recognised as CFO role expands

Amid surging regulatory demands and rapidly evolving industry, Australia’s most influential Chief Financial Officers will be honoured at the inaug...

Why outdated security leaves small businesses exposed to crime

Small and medium businesses in Australia are under increasing pressure to address security gaps that criminals readily exploit. An unlocked door, an...